G1 Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017
Market Capitalization	208	158	233	434	684	993	712	562
Market Cap Growth	-	-32.14%	-46.33%	-36.57%	-31.09%	39.49%	26.62%	-
Enterprise Value	182	132	170	295	504	733	343	459
PE Ratio	-3.30	-3.30	-1.58	-2.93	-6.90	-8.11	-8.35	-8.67
PS Ratio	2.52	1.92	4.54	13.79	15.11	-	-	-
PB Ratio	5.89	4.47	3.39	3.03	3.86	3.89	1.99	6.02
P/FCF Ratio	-4.12	-4.12	-1.80	-3.29	-8.19	-9.71	-9.49	-11.07
P/OCF Ratio	-4.12	-4.12	-1.81	-3.29	-8.17	-9.98	-9.58	-11.13
EV/Sales Ratio	2.20	1.60	3.32	9.36	11.14	-	-	-
EV/EBITDA Ratio	-3.84	-3.84	-1.26	-2.07	-5.28	-6.00	-4.03	-7.64
EV/EBIT Ratio	-3.78	-3.78	-1.26	-2.06	-5.25	-5.99	-4.02	-7.63
EV/FCF Ratio	-3.43	-3.43	-1.32	-2.23	-6.03	-7.17	-4.57	-9.02
Debt / Equity Ratio	1.58	1.58	1.20	0.57	0.16	0.04	-	-
Debt / EBITDA Ratio	-1.63	-1.63	-0.61	-0.58	-0.29	-0.08	-	-
Debt / FCF Ratio	-1.46	-1.46	-0.64	-0.62	-0.33	-0.09	-	-
Quick Ratio	3.20	3.20	4.40	8.23	8.87	13.64	29.87	8.87
Current Ratio	3.87	3.87	5.04	8.82	9.23	13.71	29.94	8.94
Asset Turnover	0.59	0.59	0.27	0.12	0.18	0	0	0
Interest Coverage	-3.47	-3.47	-12.98	-30.59	-54.03	-	-	-
Return on Equity (ROE)	-106.00%	-106.00%	-209.90%	-76.00%	-49.10%	-41.00%	-31.10%	-105.90%
Return on Assets (ROA)	-34.00%	-34.00%	-77.70%	-54.80%	-39.80%	-38.10%	-29.60%	-65.20%
Return on Capital (ROIC)	-43.30%	-43.30%	-89.96%	-63.18%	-47.04%	-48.68%	-24.88%	-65.28%
Earnings Yield	-23.03%	-30.34%	-63.33%	-34.17%	-14.50%	-12.33%	-11.98%	-11.54%
FCF Yield	-18.41%	-24.25%	-55.42%	-30.43%	-12.21%	-10.30%	-10.53%	-9.04%
Buyback Yield / Dilution	-18.58%	-18.58%	-4.01%	-10.73%	-1.01%	-12.55%	-83.08%	-1123.82%
Total Shareholder Return	-18.58%	-18.58%	-4.01%	-10.73%	-1.01%	-12.55%	-83.08%	-1123.82%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).